Epidemiology and biology of a herpesvirus in rabies endemic vampire bat populations
Rabies is a viral zoonosis transmitted by vampire bats across Latin America. Substantial public health and agricultural burdens remain, despite decades of bats culls and livestock vaccinations. Virally vectored vaccines that spread autonomously through bat populations are a theoretically appealing solution to managing rabies in its reservoir host. We investigate the biological and epidemiological suitability of a vampire bat betaherpesvirus (DrBHV) to act as a vaccine vector. In 25 sites across Peru with serological and/or molecular evidence of rabies circulation, DrBHV infects 80-100% of bats, suggesting potential for high population-level vaccine coverage. Phylogenetic analysis reveals host specificity within neotropical bats, limiting risks to non-target species. Finally, deep sequencing illustrates DrBHV super-infections in individual bats, implying that DrBHV-vectored vaccines might invade despite the highly prevalent wild-type virus. These results indicate DrBHV as a promising candidate vector for a transmissible rabies vaccine, and provide a framework to discover and evaluate candidate viral vectors for vaccines against bat-borne zoonoses.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Nature communications - 11(2020), 1 vom: 23. Nov., Seite 5951 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Griffiths, Megan E [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 17.12.2020 Date Revised 30.03.2024 published: Electronic figshare: 10.6084/m9.figshare.13090214 Citation Status MEDLINE |
---|
doi: |
10.1038/s41467-020-19832-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317970305 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM317970305 | ||
003 | DE-627 | ||
005 | 20240330233945.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41467-020-19832-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1356.xml |
035 | |a (DE-627)NLM317970305 | ||
035 | |a (NLM)33230120 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Griffiths, Megan E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epidemiology and biology of a herpesvirus in rabies endemic vampire bat populations |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.12.2020 | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a figshare: 10.6084/m9.figshare.13090214 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Rabies is a viral zoonosis transmitted by vampire bats across Latin America. Substantial public health and agricultural burdens remain, despite decades of bats culls and livestock vaccinations. Virally vectored vaccines that spread autonomously through bat populations are a theoretically appealing solution to managing rabies in its reservoir host. We investigate the biological and epidemiological suitability of a vampire bat betaherpesvirus (DrBHV) to act as a vaccine vector. In 25 sites across Peru with serological and/or molecular evidence of rabies circulation, DrBHV infects 80-100% of bats, suggesting potential for high population-level vaccine coverage. Phylogenetic analysis reveals host specificity within neotropical bats, limiting risks to non-target species. Finally, deep sequencing illustrates DrBHV super-infections in individual bats, implying that DrBHV-vectored vaccines might invade despite the highly prevalent wild-type virus. These results indicate DrBHV as a promising candidate vector for a transmissible rabies vaccine, and provide a framework to discover and evaluate candidate viral vectors for vaccines against bat-borne zoonoses | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
700 | 1 | |a Bergner, Laura M |e verfasserin |4 aut | |
700 | 1 | |a Broos, Alice |e verfasserin |4 aut | |
700 | 1 | |a Meza, Diana K |e verfasserin |4 aut | |
700 | 1 | |a Filipe, Ana da Silva |e verfasserin |4 aut | |
700 | 1 | |a Davison, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Tello, Carlos |e verfasserin |4 aut | |
700 | 1 | |a Becker, Daniel J |e verfasserin |4 aut | |
700 | 1 | |a Streicker, Daniel G |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 11(2020), 1 vom: 23. Nov., Seite 5951 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2020 |g number:1 |g day:23 |g month:11 |g pages:5951 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-020-19832-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2020 |e 1 |b 23 |c 11 |h 5951 |